2013
Parens E, Appelbaum AS, Chung W; Hastings Center Report, July-August 2013; 43(4):16–19
The rise of technologies that can inexpensively sequence entire genomes means that researchers and clinicians have access to ever vaster stores of genomic data, ...
Read more »
The FDA and 23andMe: Overreaching and overreacting?